Business Context and Reporting Period
Quanterix Corporation, an emerging growth company incorporated in Delaware, filed this Form 8-K on March 19, 2019. The report details the entry into a material definitive agreement regarding a new equity financing program.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, or debt levels. The only financial metric disclosed is the aggregate offering price of up to $50.0 million for the proposed at-the-market offering program.
Material Changes
On March 19, 2019, the Company entered into a Sales Agreement with Cowen and Company, LLC. This agreement establishes an at-the-market offering program allowing Quanterix to sell shares of its common stock through Cowen as a sales agent. The issuance is contingent upon the effectiveness of a registration statement on Form S-3 filed on the same date.
Guidance, Outlook, and Management Commentary
- Commission Structure: The Company will pay Cowen a commission equal to 3.0% of the gross sales proceeds of any shares sold under the agreement.
- Discretion: The Company is not obligated to make any sales of common stock under the agreement and retains sole discretion over the timing and parameters of sales.
- Termination: The offering will terminate upon the earlier of the sale of all placement shares or the termination of the Sales Agreement.
- Risks: The Company makes no assurances regarding when or if the registration statement will become effective.
Investor Verification Checklist
- Verify the effectiveness status of the Form S-3 registration statement filed on March 19, 2019.
- Monitor future filings for actual sales volumes and proceeds generated under the at-the-market program.
- Review the impact of the 3.0% commission on net proceeds from any future share sales.
- Check for any subsequent amendments or terminations of the Sales Agreement with Cowen.